Discrepant outcomes in two Brazilian patients with Bloom syndrome and Wilms' tumor: Two case reports

被引:8
作者
Moreira M.B. [1 ,2 ,3 ]
Quaio C.R.D. [1 ]
Zandoná-Teixeira A.C. [1 ]
Novo-Filho G.M. [1 ]
Zanardo E.A. [1 ]
Kulikowski L.D. [2 ]
Kim C.A. [1 ]
机构
[1] Instituto da Criança, Hospital das Clínicas, Universidade de São Paulo, São Paulo, SP
[2] Department of Pathology, Hospital das Clínicas, Universidade de São Paulo, São Paulo, SP
[3] Unidade de Genética Do Instituto da Criança, HC FMUSP, São Paulo, SP, Av. Dr. Eneas Carvalho de Aguiar, 647
关键词
Bloom syndrome; Cancer risk; Chromosomal instability; Sister chromatid exchange; Wilms' tumor;
D O I
10.1186/1752-1947-7-284
中图分类号
学科分类号
摘要
Introduction. Bloom syndrome is a rare, autosomal recessive, chromosomal instability disorder caused by mutations in the BLM gene that increase the risk of developing neoplasias, particularly lymphomas and leukemias, at an early age. Case presentation. Case 1 was a 10-year-old Brazilian girl, the third child of a non-consanguineous non-Jewish family, who was born at 36 weeks of gestation and presented with severe intrauterine growth restriction. She had Bloom syndrome and was diagnosed with a unilateral Wilms' tumor at the age of 3.5 years. She responded well to oncological treatment and has remained disease-free for the last 17 years. Case 2 was a 2-year-old Brazilian girl born to non-Jewish first-degree cousins. Her gestation was marked by intrauterine growth restriction. She had Bloom syndrome; a unilateral stage II Wilms' tumor was diagnosed at the age of 4 years after the evaluation of a sudden onset abdominal mass. Surgical removal, neoadjuvant chemotherapy and radiotherapy were not sufficient to control the neoplasia. The tumor recurred after 8 months and she died from clinical complications. Conclusion: Our study reports the importance of rapid diagnostics and clinical follow-up of these patients. © 2013Moreira et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 19 条
  • [1] Bloom D., Congenital telangiectatic erythema resembling lupus erythematosus in dwarfs, Amer J Dis Child, 88, pp. 754-758, (1954)
  • [2] German J., Bloom's syndrome I. Genetical and clinical observations in the first twenty-seven patients, Am J Genet, 21, pp. 196-227, (1969)
  • [3] Ellis N.A., Groden J., Ye T.Z., Straughen J., Lennon D.J., Ciocci S., Proytcheva M., German J., The Bloom syndrome gene product is homologous to RecQ helicases, Cell, 83, pp. 655-666, (1995)
  • [4] German J., Bloom syndrome: A mendelian prototype of somatic mutational disease, Medicine, 72, pp. 393-406, (1993)
  • [5] Sanz M.M., German J., Bloom's syndrome [2006, updated 2013], GeneReviews, (1993)
  • [6] Skorski T., BCR/ABL, DNA damage and DNA repair: Implications for new treatment concepts, Leukemia and Lymphoma, 49, 4, pp. 610-614, (2008)
  • [7] Dome J.S., Coppes M.J., Recent advances in Wilms tumor genetics, Current Opinion in Pediatrics, 14, 1, pp. 5-11, (2002)
  • [8] Cairney A.E.L., Andrews M., Greenberg M., Smith D., Weksberg R., Wilms tumor in three patients with Bloom syndrome, Journal of Pediatrics, 111, 3, pp. 414-416, (1987)
  • [9] Berger C., Frappaz D., Leroux D., Blez F., Vercherat M., Bouffet E., Jalbert P., Brunat-Mentigny M., Tumeur de Wilms et syndrome de Bloom, Archives de Pediatrie, 3, 8, pp. 802-805, (1996)
  • [10] German J., Bloom's syndrome. XX. The first 100 cancers, Cancer Genetics and Cytogenetics, 93, 1, pp. 100-106, (1997)